MWPCG
BIIB icon

Measured Wealth Private Client Group’s Biogen BIIB Stock Holding History

Measured Wealth Private Client Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-132
Closed -$46K – 169
2018
Q3 		$46K Buy
+132
New +$45.4K 0.03% 374

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Measured Wealth Private Client Group's BIIB Position: Q4 2018 in Review

Measured Wealth Private Client Group sold out of Biogen (BIIB) in Q4 2018, closing a stake of 132 shares — an estimated $46K sold.

Measured Wealth Private Client Group first reported a position in BIIB in Q3 2018 and held it in 1 quarter. The position peaked at $46K in Q3 2018. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Measured Wealth Private Client Group reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Measured Wealth Private Client Group sold 132 Biogen shares in Q4 2018, an estimated $46K.
  • Measured Wealth Private Client Group first reported a position in Biogen in Q3 2018 and held it in 1 quarter.
  • Measured Wealth Private Client Group's Biogen position peaked at $46K in Q3 2018.
  • 1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Measured Wealth Private Client Group's 13F filing for Q4 2018, filed 7 Feb 2019.